Events

IRVING INSTITUTE TRANSLATIONAL THERAPEUTICS SYMPOSIUM: ACCELERATING DRUG DEVELOPMENT IN THE ERA OF PRECISION MEDICINE The Translational Therapeutics Accelerator of the Irving Institute for Clinical and Translational Research is hosting a symposium to share successful advancement of early stage science to clinical applications. The full-day event will feature speakers from Academia and industry, a lunch and poster session and opportunities to network with colleagues in the area of drug development. Wednesday, November 7th 8:30AM - 5:00PM Columbia University Irving Medical Center, Bard Hall 50 Haven Avenue New York, NY 10032 https://2018precisionmedicine.splashthat.com/ Registration Opens: 8:30am Welcome: 9:00am Muredach P. Reilly, MB, MS Director, Irving Institute Florence and Herbert Irving Endowed Professor of Medicine Session I: Therapeutic Development in Cancer 9:10am - 11:00am Wafik El-Deiry, MD, PhD Deputy Cancer Center Director, Professor of Oncology at Fox Chase Cancer Center Mark Kester, PhD Director, The NanoSTAR Institute, Professor of Pharmacology at the University of Virginia Patrick Mayes, PhD Executive Director, Head of Immuno-oncology, Incyte Panel Q&A and Break Session II: Advancements in Drug Discovery and Development 11:00am - 12:10pm Chas Bountra, PhD Chief Scientist at the Structural Genomics Consortium, Professor of Translational Medicine at Oxford University Julia Glade-Bender, MD Vice Chair for Clinical Research, Department of Pediatrics at Memorial Sloan Kettering Cancer Center Panel Q&A Lunch and Poster Session Session III: The Road from Bench to Bedside 1:15pm – 3:05pm Angela Christiano, PhD Professor of Dermatology, Genetics & Development at Columbia University Olivier Harari, MD, PhD Vice President of Therapeutic Areas, Early Clinical Development at Regeneron Pharmaceuticals Konstantin Petrukhin, PhD Associate Professor of Ophthalmology at Columbia University Panel Q&A and Break Session IV: Therapeutic Development in Orphan Diseases 3:05pm - 5:00pm Michael Spector, MBA President and CEO, Caelum Biosciences Michio Hirano, MD Chief, Division of Neuromuscular Disorders, Professor of Neurology at Columbia University James Wilson, MD, PhD Director, Gene Therapy Program, Rose H. Weiss Professor and Director of Orphan Disease Center, Professor of Medicine and Pediatrics at University of Pennsylvania To register, click the link: https://2018precisionmedicine.splashthat.com/ For questions please email [email protected]